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IL-6Ischemia and reperfusion injury (IR) is an antigen independent inﬂammatory process that causes tissue
damage. After IR, kidneys up-regulate leukocyte adhesion molecules and toll-like receptors (TLRs). Moreover,
injured kidneys can also secrete factors (i.e. heat shock protein) which bind to TLRs and trigger intracellular
events culminating with the increase in the gene expression of inﬂammatory cytokines.
FTY720 is an immunomodulatory compound and protects at least in part kidneys submitted to IR. The
mechanisms associated with FTY720's beneﬁcial effects on kidneys after IR remain elusive. We investigated
whether FTY720 administration in mice submitted to kidney IR is associated with modulation of TLR2 and
TLR4 expression. C57BL/6 mice submitted to 30 min of renal pedicles clamp were evaluated for serum
parameters (creatinine, urea and nitric oxide), kidney histology, spleen and kidney inﬁltrating cells
expression of TLR2 and TLR4, resident kidney cells expression of TLR2 and TLR4 and IL-6 protein expression in
kidney.
FTY720-treated mice presented decrease in serum creatinine, urea and nitric oxide, diminished expression of
TLR2 and TLR4 both in spleen and kidney inﬁltrating cells, and reduced kidney IL-6 protein expression in
comparison with IR non-treated mice. However, acute tubular necrosis was present both in IR non-treated
and IR+FTY720-treated groups. Also, FTY720 did not prevent TLR2 and TLR4 expression in kidney resident
cells.
In conclusion, FTY720 can promote kidney function recovery after IR by reducing the inﬂammatory process.
Further studies are needed in order to establish whether TLR2 and TLR4 down regulation should be
therapeutically addressed as protective targets of renal function and structure after IR.IFESP Federal University of São
eno).
vier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The pathogenesis of kidney ischemia and reperfusion injury (IR)
involves a complex interaction of parameters including renal hemody-
namics, tubular injury and inﬂammatory responses. After IR, kidneys are
not merely passive targets of the immune-mediated injury but in turn
they up-regulate leukocyte adhesion molecules and toll-like receptors.
Toll-like receptors (TLRs) are a family of transmembraneproteins that in
addition to binding to a range of microbial products can also recognize
endogenous ligands termed danger-associated molecular patterns
(DAMPs). TLR2 and TLR4 bind to heat shock proteins (HSP), high
mobility group box 1 (HMGB1) and breakdown products of ﬁbronectin,
heparan sulfate and hyaluronic acid. After TLR activation an intracellular
cascade of events occurs resulting in the release of NF-κB from IκB,
allowing NF-κB translocation from cytoplasm to nucleus where itmediates the increase in inﬂammatory cytokine gene expression
leading to pro-inﬂammatory responses [1,2].
In the kidney TLR2 and TLR4 are constitutively expressed in both
proximal and distal tubules, the thin limb of the loop of Henle and the
collecting ducts with their up regulation in these sites after IR [3].
Rats submitted to 45 minutes of renal pedicles clamping and
evaluated 24 h later presented an increase of the HSP70 protein
expression on renal tubular cells with this expression peaking on day
3. An increase in the mRNA expression for TLR2 and TLR4 was also
found on day 3. This result was conﬁrmed by immunohistochemistry
with TLR2 and TLR4 expressed in the injured proximal tubules and
thick ascending limbs [4]. These ﬁndings suggest that renal tubular
cells are the main source of HSP70 in IR and can activate toll-like
receptors which are also present in this site.
Tubular epithelial cells (TECs) from TLR2−/−mice submitted to in
vitro IR produced signiﬁcantly less IL-6 than TECs fromwild typemice.
These results were conﬁrmed using IR in vivo model (45 min of renal
pedicles clamping) showing that C57BL/6 wild type mice produced
more IL-6 than TLR2−/− mice [5].
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Fig. 1. Serum creatinine (A), serumurea (B) and serumnitrite (C) in Control, ischemia/
reperfusion injury non-treated (IR) and FTY720-treated mice (IR+FTY).
***pb0.0001.
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anisms associated with renal IR and are essential for the development
of therapeutic strategies. As an example, Liu et al. showed that the
administration of Eritoran (TLR4 inhibitor) to mice submitted to
kidney IR decreased serum creatinine, attenuated renal tissue damage
and diminished the expression of IL-6 mRNA [6].
Our group showed previously [7,8] that FTY720 treatment
attenuates kidney damage and decreases kidney inﬁltrating cells in
C57BL/6 mice submitted to IR. Therefore, our aim in the present study
was to investigate whether the protective effects on kidney after IR
due to FTY720 administration are associated with the modulation of
TLR2 and TLR4 expression.
2. Materials and methods
Eight- to 10-week-old male C57BL/6 mice were anesthetized with
a subcutaneous injection of a ketamine/xylazine (Vetbrands, São
Paulo, Brazil) preparation.
Through a midline abdominal incision, the left and right renal
vessels were bluntly dissected and occluded with a nontraumatic
vascular clamp for 30 min. After both clamps were released, kidneys
showed immediate restoration of renal blood ﬂow excluding the
possibility of a vascular thrombus. Finally, the abdominal incision was
sutured and animals were returned to their cages for 24 h.
After this period and under anesthesia, 1 mL of blood was obtained
from the vena cava to determine plasma creatinine (Cr), urea (UR),
nitric oxide (NO) and lymphocytes (%).
Spleen was removed for ﬂow cytometry evaluation of TL2 and
TLR4.
Kidneys were removed either for histology, ﬂow cytometry (TLR2
and TLR4), immunohistochemistry or Western blot evaluations.
2.1. FTY720 treatment
Immediately before renal pedicles clamping, 1 mg/kg of FTY720
(Novartis, Switzerland) was injected intravenously in the treated
group (IR+FTY) whereas the non-treated group (IR) was submitted
to ischemia-reperfusion only.
2.2. Renal parameters
Bloodwas collected and centrifuged at 1500 rpm for 5 min for serum
collection. Serum creatinine concentration was assessed using a
colorimetric assay (Creatinina, LabtestDiagnóstica/Brazil) basedon Jaffe's
reaction. Serum urea concentration was measured using an enzymatic
colorimetric assay (Uréia CE, Labtest Diagnóstica/Brasil). Absorbance
measurements were obtained at Genesys 5 (Spectronic/Denmark).
2.3. Nitric oxide measurement
Peripheral blood samples from C57BL/6micewere centrifuged and
stored at −80 °C until analysis. The assay is based on the enzymatic
conversion of nitrate to nitrite by nitrate reductase. Nitrite was
measured in blood serum samples by enzyme linked immunosorbent
assay (ELISA). Samples (50 μl) were added to a 96 well plate with
50 μl of Griess solution and the absorbance was measured in a TP
reader (Thermo Plate) in 550 nmwith the obtained values adjusted to
the standard curve. All samples were measured in triplicate.
2.4. Blood smear
In order to determine the differential (neutrophils, monocytes,
lymphocytes) percentage of circulating leukocytes we collected blood
(10 μL) from the vena cava and dropped it toward one end of a slide
andwith a cover slip it was smeared back over the slide. A Panotico kit(Laborclin, Paraná, Brazil) was used for staining and leukocytes were
identiﬁed and counted under the microscope.
2.5. Cell suspensions
Kidneys and spleens were disrupted by a syringe plunge in
phosphate buffered solution (PBS). The resulting cell suspension was
forced through a 70 μm cell strainer mesh (BD Falcon, USA) and
collected in a 15 ml Falcon tube. From this cell suspension 5 μl was
added to 95 μl of Trypan blue for cell viability counting in Neubauer
chamber under a microscope. It was possible to observe that the cell
suspension was composed mostly of leukocytes with occasional
appearance of cell debris. After cell counting they were adjusted for
1×106/ml.
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Kidney inﬁltrating cells and splenocytes (1×106) were stained
(30 min) with puriﬁed rat anti-mouse TLR4 (BD Pharmingen™) or
puriﬁed rat anti-mouse TLR2 (R&D Systems) monoclonal antibodies.
Cells were washed in ice-cold PBS (Sigma-Aldrich Brasil Ltda) and
stained (30 min) with anti-rat IgG FITC (BD Pharmingen™) secondary
antibody.
2.7. Kidney histology
4% formalin-ﬁxed kidneys embedded in parafﬁn were sectioned
and stained with H&E and their structures evaluated by a pathologist
blinded to the treatment arm.
2.8. Immunohistochemistry
Kidney sections of 5 μM were deparafﬁnized in xylene and
rehydrated in graded ethanol, then pretreated in a microwave
(Eletrolux, SP, Brazil) with 10 mM citric acid buffer (pH=6) for
3 cycles of 5 min each at 850 W for antigen retrieval. They were pre-
incubated with 0.3% hydrogen peroxidase in PBS during 5 min for
inactivation of endogenous peroxidase, and then blocked with 5%
normal goat serum in PBS for 10 min. The specimens were then
incubated with anti-TLR2 polyclonal antibody (H-175:sc-10739, Santa
Cruz Biotechnology, CA, USA) or anti-TLR4 polyclonal antibody (M-300:
sc-30002, Santa Cruz Biotechnology, CA, USA) both at a concentration of
1:500. Incubation was carried out overnight at 4°C within the
refrigerator. This was followed by two washes in PBS for 10 min.
Sections were then incubated with anti-rabbit biotin-conjugatedFig. 2. Kidney histology after 24 h of ischemia/reperfusion injury in non-treated
(IR 200×; A) and FTY720-treated mice (IR+FTY 200×; B).
Co
ntr
ol
IR+
FT
YIR
Fig. 3. Percentage of lymphocytes in peripheral blood (A) and number of cells in spleen
(B) from Control, ischemia/reperfusion injury non-treated (IR) and FTY720-treated
mice (IR+FTY). ***pb0.0001; ns=not signiﬁcant (p=0.256).secondary antibody (Vector Laboratories, CA, USA) at a concentration
of 1:200 in PBS for 1 h. After that, sections were washed twice with PBS
followed by the application of preformed avidin biotin complex
conjugated to peroxidase (Vector Laboratories, CA, USA) for 45 min.
The bound complexes were visualized by the application of a 0.05%
solution of 3-3′ –diaminobenzidine (DAB) solution.2.9. Kidney Western blot for IL-6 protein
A solubilization buffer containing 100 mM Tris, pH 7.6, 1% Triton
X-100, 0.01 mg/mL aprotinin, 2 mM PMSF, 10 mM Na3VO4, 10 mM
NaF, 10 mM Na4P2O7, and 10 mM EDTA was added to the kidney and
the organ was sonicated. Insoluble material was removed by 30 min
centrifugation at 11,000 rpm/4 °C. The supernatant was used to
measure pprotein concentration (Bradford - ELISA assay). IL-6 protein
expression was determined by loading protein samples (50 μg) into
10% SDS-polyacrylamide gel. Electrotransfer of proteins from the gel
to nitrocellulose membrane was performed for 90 min at 120 V. To
reduce non-speciﬁc protein binding to the nitrocellulose membrane,
the ﬁlter was preincubated overnight at 4 °C in a blocking buffer (5%
nonfat dry milk, 10 mM Tris, 150 mM NaCl and 0.02% Tween 20). The
nitrocellulose membrane blots were incubated overnight at 4 °C with
anti-IL-6 antibody (R&D Systems) diluted in blocking buffer (3%
nonfat drymilk, 10 mMTris, 150 mMNaCl and 0.02% Tween 20). After
that, the membranes were incubated with secondary antibody
conjugated to horseradish diluted in blocking buffer (1% nonfat dry
milk, 10 mM Tris, 150 mM NaCl and 0.02% Tween 20) for 60 min. To
1314 J.F. Pedregosa et al. / International Immunopharmacology 11 (2011) 1311–1318visualize the autoradiography, enhanced chemiluminescence re-
agents were used and the membranes were exposed to preﬂashed
Kodak XAR ﬁlm (Eastman Kodak, Rochester, NY). Quantitative
analysis was done using Scion Image software (Frederick, MD, USA).
2.10. Statistical analysis
Data are expressed as mean and standard deviation and the
statistical analysis was performed by ANOVA followed by Tukey's
pairwise comparisons. The level of statistical signiﬁcance was deﬁned
as p-value b0.05.
3. Results
In Fig. 1 it is shown that 24 h after IR there was a signiﬁcant
increase in serum creatinine, urea and nitrite in IR non-treated group
(IR) when compared with Control. FTY720 treatment (IR+FTY)
caused a signiﬁcant decrease in serum creatinine and urea but these
parameters were still higher than those from the Control group. On
the other hand, serum nitrite was signiﬁcantly lower in FTY720-
treated mice even when compared with the Control group. Kidney
tissue evaluated by histology presented acute tubular necrosis (ATN)
in both groups (IR and IR+FTY) as shown in Fig. 2.
IR caused signiﬁcant lymphopenia both in non-treated and
FTY720-treated mice with a higher decrease in the number of%
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Fig. 4. Percentage of spleen lymphocytes TLR2+ (A), spleen non-lymphocytes TLR2+ (C)
ischemia/reperfusion injury non-treated (IR) and FTY720-treated mice (IR+FTY). **p=0.0lymphocytes in treated animals. This ﬁnding conﬁrms the already
described effect of FTY720-causing lymphopenia. On the other hand,
there was no statistical difference in cell numbers from the spleen
when Control, IR and IR+FTY groups were compared (Fig. 3).
After IR there was a signiﬁcant increase in the expression of TLR2
in lymphocytes and non-lymphocytes spleen cells. FTY720 treatment
decreased TLR2 expression to Control levels (Fig. 4A and C). In IR non-
treated mice the percentage of TLR4 expression in spleen cells also
increased (lymphocytes and non-lymphocytes) and FTY720 treat-
ment caused a TLR4 expression in lymphocytes similar to Control
group whereas in non-lymphocytes FTY720 led to a signiﬁcant
decrease in TLR4 expression but it was still higher than in Control
(Fig. 4B and D).
Kidney inﬁltrating cells (KIC) were similar in number when all
groups were compared (Fig. 5A). However, when TLR2 percentage
was evaluated in KIC we found a signiﬁcant increase of this marker in
IR non-treated mice. Moreover, the treatment with FTY720 caused a
signiﬁcant decrease in TLR2 expressed in KIC (Fig. 5B). TLR4
expression increased signiﬁcantly after IR in non-treated mice in
comparisonwith Control animals and the treatmentwith FTY720 only
partially decreased the percentage of this marker expression in KIC
(Fig. 5C).
The evaluation of TLR2 and TLR4 expression in kidney resident
cells showed strong positivity for both markers in IR non-treatedmice
Fig. 6. FTY720 treatment did not prevent the expression of TLR2 and0
5
10
15
20
0
5
10
15
Co
ntr
ol
IR
+F
TYIR
Co
ntr
ol
IR
+F
TYIR
***
***
***
*** ***
, spleen lymphocytes TLR4+ (B) and spleen non-lymphocytes TLR4+ (D) in Control,
01; ***pb0.0001.
00
0.5
1.0
1.5
2.0
2.5
0
10
20
30
Co
ntr
ol IR
IR
+F
TY
Co
ntr
ol IR
IR
+F
TY
Co
ntr
ol IR
IR
+F
TY
1
2
3
n
u
m
be
r o
f c
el
ls
 (x
 10
6 )
%
 T
LR
2 
in
 k
id
ne
y
in
fil
tra
tin
g 
ce
lls
%
 T
LR
4 
in
 k
id
ne
y
in
fil
tra
tin
g 
ce
lls
ns
ns ns
*** ***
***
***
A
B
C
Fig. 5. Number of kidney inﬁltrating cells (KIC) (A), percentage of KIC TLR2+ (B) and
percentage of KIC TLR4+ (C) in Control, ischemia/reperfusion injury non-treated (IR)
and FTY720-treated mice (IR+FTY). Ns=not signiﬁcant (p=0.069); ***pb0.0001.
1315J.F. Pedregosa et al. / International Immunopharmacology 11 (2011) 1311–1318TLR4 in resident cells from kidneys submitted to IR (Fig. 7). The kidney
expressed signiﬁcantly higher levels of IL-6 protein in IR non-treated
mice in comparison with Control. The treatment with FTY720
decreased the expression of IL-6 to Control levels (Fig. 8).
4. Discussion
Ischemia and reperfusion injury (IR) is an antigen independent
inﬂammatory process that causes tissue damage [9,10]. Kidney
ischemia and reperfusion is associated with endothelial injury,
leukocyte inﬁltration and tubular epithelial cell activation contribut-
ing thus to the inﬂammation process which is mediated by innate and
adaptive immune response [11–13]. In transplantation IR is one of the
risk factors for delayed graft function, acute and chronic rejection. Ourgroup showed previously in a mice model of kidney ischemia and
reperfusion injury that FTY720 treatment decreased the rate of
tubular necrosis, reduced the levels of serum creatinine and was
associated with a diminished number of lymphocyte-inﬁltrating cells
[7,8]. In the present study we observed 24 h after IR a signiﬁcant
decrease in serum creatinine and urea in FTY720-treated mice
submitted to IR. Moreover, FTY720 caused a signiﬁcant decrease in
circulating levels of nitric oxide (NO). Nitric oxide (NO) has several
functions depending on its concentration, site of release and period of
action [14]. In kidney transplantation Kwon et al. [15] showed that
patients with sustained acute kidney injury presented higher
circulating NO levels (9.1±3.4 μM) when compared with renal
function recovered and healthy control individuals (6.1±0.8 μM
and 7.9±0.9 μM respectively). Our results suggest that FTY720
protection against kidney function damage after IR may occur via
modulation of circulating NO.
In spite of the improved renal function after IR due FTY720
treatment, kidney histology showed acute tubular necrosis (ATN) in
both groups (IR and IR+FTY).
It is well known that the inﬂammatory cascade after IR includes
cell-surface innate immune receptor activation with subsequent up-
regulation of a proinﬂammatory cytokines and chemokines [16,17].
Kidney IR in rats (45 min of both renal arteries clamping) increased
TLR2 and TLR4 mRNA and protein expression mainly on renal tubular
cells [4]. Shigeoka et al. [18] showed by confocal imaging that in
C57BL/6 mice, TLR2 is highly expressed in the kidney mainly in the
renal cortex and outer stripe of the medulla (intercellular mem-
branes). Following IR injury, TLR2 expression in kidney tissue is
intracellular suggesting internalization of the protein receptor.
Authors also observed by ELISA an increase of the proinﬂammatory
cytokine IL-6 in serum and kidney homogenate after IR. IL-6 in both
sites was diminished in TLR-2 deﬁcient mice.
In our model, IR caused a signiﬁcant increase of TLR2 and TLR4
expression in spleen cells. In kidney inﬁltrating cells (KIC) there was a
signiﬁcant increase of TLR2 and TLR4 after IR in comparison with
Control mice.
Concerning to FTY720 treatment, it has been shown by Martin
et al. [19] in a model of hepatic ischemia that FTY720 not only
prevented the accumulation of CD4+ T cells in liver sinusoids but also
diminished the gene expression of TLR4 and IL-6 in hepatic tissue. In
our model it was observed that FTY720 treatment caused a reduction
of TLR2 to Control levels after IR either in cells from spleen as in KIC.
For TLR4, FTY720 treatment caused an important decrease in spleen
and KIC but not as dramatic as for TLR2. All together these data
conﬁrm that TLR2 and TLR4 expressed in leukocytes are associated
with the inﬂammatory process occurring after kidney IR. In agree-
ment Liu et al. [6] showed that the inhibitor of TLR4 (Eritoran)
administered immediately before IR in rats decreased serum
creatinine and attenuated the renal tissue damage.
Concerning TLR2 and TLR4 expression in kidney resident cells, Kim
et al. [4] recently showed that IR injury increased both TLR2 and TLR4
mRNA and protein expression in rat kidneys, and these were
predominantly expressed in PT and TAL. This ﬁnding is in agreement
with a previous report showing that TLR2 and TLR4mRNA and protein
are strongly expressed in renal tubular cells from ischemic kidneys
[2]. In our study it was shown by immunohistochemistry that TLR2
and TLR4 are expressed in kidney resident cells (cortex-medulla
transition area) from mice submitted to IR.
It has been shown that FT720 protection to kidneys submitted to IR
is associated with T cell-dependent [20] and T cell-independent [21]
mechanisms. The T cell-dependent mechanism occurs through the
lymphopenia induced by FTY720 via direct activation of sphingosine-1
phosphate receptor 1 (S1P1R) on lymphocytes. The T cell-independent
mechanism is associated with direct activation of S1P1R expressed on
renal tubule epithelial cells (PTECs). In a mouse model of kidney IR
injury, Bajwa et al. [21] concluded that the protection obtained with
Fig. 6. Dot plot analysis of spleen cells (lymphocyte gate A, red) and TLR2 expression in Control and IR non-treated mice (B, gray and green lines respectively). Dot plot analysis of
spleen cells (non-lymphocyte gate C, red) and TLR2 expression in Control and IR non-treated mice (C, gray and green lines respectively). Dot plot analysis of kidney inﬁltrating cells
(E, FSC × SSC – R2 gate) and TLR2 expression in Control and IR non-treated mice (F, gray and green lines respectively).
Fig. 7. Sections from kidneys submitted to IR and evaluated for TLR2 and TLR4 using immunohistochemistry. Ischemia and reperfusion evaluated for TLR2 in non-treated mice
(A, 40×) and in FTY720-treated mice (B, 40×). IR evaluated for TLR4 in non-treated mice (C, 40×) and in FTY720-treated mice (D, 40×).
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1317J.F. Pedregosa et al. / International Immunopharmacology 11 (2011) 1311–1318FTY720 treatment was likely due to this drug ability to inhibit cell
death of kidney PTECs by a mechanism dependent on S1P1R
expression and that may involve the Akt/ERK pathway.
We demonstrated previously [7] in C57BL/6 mice that FTY720
treatment decreases but does not prevent acute tubular necrosis
(ATN) in kidneys submitted to IR. In the present study we also
observed a diminished area of ATN (data not shown) in FTY720-
treated mice. In addition, kidney tubular epithelial cells express both
TLR2 and TLR4 which respond to endogenous “danger signals” to
initiate acute kidney injury [3]. Corroborating this hypothesis, it was
observed in our experiments a strong expression of TLR2 and TLR4 in
the cortex-medulla transition area of kidneys submitted to IR and
FTY720 treatment was not able to prevent this event. Our ﬁndings
suggest that the maintenance of TLR2 and TLR4 expression in kidney
resident cells even after FTY720 treatment could be associated with
neutrophil inﬁltration which may release reactive oxygen species
(ROS) and enzymes producing additional tissue damage [22]. In
agreement, Troncoso et al. [23] showed using the same model that
FTY720 treatment had no effect on neutrophil inﬁltration into the
renal tissue.
It has been shown that the expression of genes associated with
inﬂammation such as IL-6 is increased after IR. High circulating levels
of IL-6 have been considered a marker of inﬂammatory response
severity after IR [24,25]. Cicora et al. [26] showed that even in
autotransplantation there is a signiﬁcant increase in serum levels of
creatinine and urea 24 h after IR. The group also observed an increased
expression of IL-6 (immunohistochemistry) in the renal tissue. All
these parameterswere diminished due to the previous treatmentwith
a single dose of immunosuppressive drugs (MMF, Rapamycin or
Tacrolimus). In our model, the expression of IL-6 protein on renal
tissue was signiﬁcantly increased after IR. The treatment with FTY720
reduced IL-6 protein expression to Control levels.
After kidney IR injury a cascade of events is triggered leading to
tubular injury, endothelial dysfunction and inﬂammation. Through the
inhibition of these events an ideal treatment should limit the damage
caused in both renal tissue and function. FTY720 is a non-selective S1P
receptor agonist and partially protects the kidney from IR injury as our
results showed improvement of renal function and reduction but not
total inhibition of acute tubular necrosis. Corroborating our data, Lien
et al. [27] showed that even using a S1P1-selective agonist (SEW2871)
it was possible only to improve renal function and reduce tubular
necrosis scores (IR=4.3 vs. IR+SEW2871=2.5) without inhibiting
completely the damage caused by IR.
In conclusion, our study shows that FTY720 treatment causes a
reduced expression of TLR2 and TLR4 in spleen cells and KIC but does
not prevent TLR2 and TLR4 expression in kidney resident cells 24 h
after ischemia and reperfusion injury. Moreover, the decreased
circulating NO and diminished kidney expression of IL-6 in FTY720-treated mice suggest that the drug acts in several steps of the
inﬂammatory process and thus protects the kidney at least in part
from the damage caused by IR. Further studies are needed in order to
establish whether TLR2 and TLR4 down regulation should be
therapeutically addressed as protective targets of renal function and
structure after IR.
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